共4页/73条首页上一页1234下一页尾页
回复:74 阅读:10101
介绍最新胃肠肿瘤分级手册:AJCC Cancer Staging Manual(2010): 上: 胃癌分级

谈东风 离线

帖子:255
粉蓝豆:14
经验:336
注册时间:2010-04-09
加关注  |  发消息
楼主 发表于 2010-05-04 12:29|举报|关注(0)
浏览排序[ 顺序 逆序 楼主 支持 精彩 ]  快捷回复
姓    名: ××× 性别:   年龄:  
标本名称:  
简要病史:  
肉眼检查:  

 

New TNM  in the Staging of Gastric Cancer

 

Dongfeng Tan, MD

 

 

 

Introduction

 

    Properly staging cancer allows the clinician to choose the appropriate treatment modalities, reliably evaluate and predict outcomes of disease management, and uniformly document cancer cases worldwide. Although there are several classification systems for gastric cancer, the Cancer Staging Manual developed by the American Joint Committee on Cancer (AJCC) with support from International Union for Cancer Control (UICC), the American Cancer Society, American College of Surgeons, American Society of Clinical Oncology, and International Union against Cancer, is the generally accepted classification system. The cancer-staging criteria have been continually refined since 1959, with the combined efforts of medical community, and multiple medical and oncology organizations. The latest edition (7th edition) of the AJCC Cancer Staging Manual was published in early 2010. In the new edition, the AJCC and UICC used large datasets and emerging evidence to support changes in the cancer staging criteria in general, and they used data sets from Asia, Europe, and the United States for the gastric cancer staging systems in particular.

 

    In the new edition of the AJCC staging manual, tumors arising at the EGJ, or arising within the proximal 5 cm of the stomach (cardia) that extends into the EGJ or esophagus, are staged using the TNM system for adenocarcinoma of the esophagus. All other cancers with a midpoint in the stomach lying more than 5 cm distal to the EGJ, or those within 5 cm of the EGJ but not extending into the EGJ or esophagus, are staged using the gastric cancer staging system.

 

DEFINITIONS OF TNM

    TNM staging describes three major anatomic characteristics of cancer: 1) the location and extension of the primary tumor, 2) the presence or absence of lymph node involvement, and 3) the presence or absence of distant tumor metastasis. These features can be evaluated by physical examination, imaging studies, and histopathologic evaluation. All cancers, though, should be confirmed histologically.

 

    Before pathologic staging, efforts should be made to differentiate primary gastric cancer from metastatic disease, which is not an uncommon event. After the primary gastric cancer is established, gastric cancer should be classified. Majority of gastric cancer is adenocarcinoma. The histological subtypes of gastric cancer are listed in Table 1. 

 

Table 1.  The histological subtypes of gastric cancer

------------------------------------------------------

 

            Adenocarcinoma (more than 90%)

            Adenosquamous carcinoma

            Mucinous adenocarcinoma

            Papillary adenocarcinoma

            Signet ring cell carcinoma

            Squamous cell carcinoma

            Tubular adenocarcinoma

            Undifferentiated carcinoma

-------------------------------------------------------

 

    Pathologically, the extent of the tumor needs to be carefully assessed. Pathologic staging depends on data acquired clinically together with findings on subsequent gross and microscopic examination of the surgically resected specimen.

 

    Of note, the TNM staging recommendations apply only to carcinomas. Lymphomas, sarcomas, and carcinoid tumors (well-differentiated neuroendocrine tumors) are excluded. Mixed glandular/neuroendocrine carcinomas should be staged using the gastric carcinoma staging system for well-differentiated gastrointestinal neuroendocrine tumors.

 

Designation of primary gastric cancer status     

    Staging of primary gastric adenocarcinoma is dependent on the extension and depth of penetration of the primary tumor. Histologically, the wall of the stomach has five layers: mucosa, submucosa, muscular propria, subserosal connective tissue, and serosal surface.

 

    One of the major changes to the T designation for gastric cancer in the 7th edition of the AJCC Cancer Staging Manual is that the T categories have been modified to correspond to the T categories for cancers of the esophagus and small and large intestine. Specifically, T1 lesions have been subdivided into T1a and T1b, which are defined as tumor invades muscularis mucosae and tumor invades submucosa, respectively; T2 is defined as a tumor that invades the muscularis propria; T3 is defined as a tumor that invades the subserosal connective tissue (formerly T2b in AJCC Cancer Staging Manual, 6th edition); and T4 is defined as a tumor that invades the serosa (visceral peritoneum, formerly T3 in AJCC Cancer Staging Manual, 6th edition) or adjacent structures. The T (primary tumor) designation of gastric cancer is listed in Table 2.

 

Table 2.    Primary Tumor (T) of Gastric Cancer

________________________________________________________________________

TX        Primary tumor cannot be assessed

T0        No evidence of primary tumor

Tis       Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria

T1        Tumor invades lamina propria, muscularis mucosae, or submucosa

T1a      Tumor invades lamina propria or muscularis mucosae

T1b      Tumor invades submucosa

T2        Tumor invades muscularis propria

T3        Tumor penetrates subserosal connective tissue without invasion of visceral peritoneum or adjacent structures *

T4        Tumor invades serosa (visceral peritoneum) or adjacent structures *

T4a      Tumor invades serosa (visceral peritoneum)

T4b      Tumor invades adjacent structures

________________________________________________________________________

 

*The adjacent structures of the stomach include the spleen, transverse colon, liver, diaphragm, pancreas, abdominal wall, adrenal gland, kidney, small intestine, and retroperitoneum.

 

 

Designation of regional lymph node status

 

    The regional lymph nodes of the stomach are roughly divided into two major groups: 1) the perigastric nodes, which include nodes in the greater curvature of the stomach and nodes in the lesser curvature of the stomach, and 2) the local nodes in the pancreatic and splenic area.

Adequate dissection of these regional nodal areas is important to ensure the appropriate pN designations and final staging. For pathologic assessment, the regional lymph nodes are removed and examined histologically to evaluate the total number of lymph nodes as well as the number that contain metastatic tumors. N categories have been modified in the new AJCC staging manual, with N1=1-2 positive regional lymph nodes, N2=3-6 positive regional lymph nodes (N1 in the 6th edition of AJCC staging manual) and N3=7 or more positive regional lymph nodes. In addition, metastatic nodules in the fat adjacent to a gastric carcinoma, without evidence of residual lymph node tissue, are considered regional lymph node metastases. Although it has been suggested that pathologists assess at least 16 regional lymph nodes, a pN determination may be assigned on the basis of the actual number of nodes evaluated microscopically. The N (regional lymph node) designation of gastric cancer is listed in Table 3.

 

Table 3.  Regional Lymph Nodes (N) of Gastric Cancer

________________________________________________________________________

NX       Regional lymph node(s) cannot be assessed

N0       No regional lymph node metastasis*

N1       Metastasis in 1-2 regional lymph nodes

N2       Metastasis 3-6 regional lymph nodes

N3       Metastasis in seven or more regional lymph nodes

N3a      Metastasis in 7-15 regional lymph nodes

N3b      Metastasis in 16 or more regional lymph nodes

________________________________________________________________________

 

*Note: A designation of pN0 should be used if all examined lymph nodes are negative, regardless of the total number removed and examined.

 

Designation of distant metastasis status:

 

    Two designations of metastatic status are included in the 7th edition of the AJCC Cancer Staging Manual, namely, M0: No distant metastasis, and  M1:Distant metastasis. Note, no Mx designation was mentioned in the 7th edition of the AJCC Cancer Staging Manual.

 

    Distant metastasis means that the tumor has disseminated to distant lymph nodes or a distant organ system.    The distant lymph nodes of gastric cancer include retropancreatic, hepatoduodenal, para-aortic, portal, retroperitoneal, and mesenteric. Involvement of these intra-abdominal lymph nodes is classified as distant metastasis. Other metastatic sites include distant organs (liver, lungs, and central nervous system) and peritoneal surfaces (tumor implants). Positive peritoneal cytology is now classified as metastatic disease (M1). A summary of designation of distal metastatic tumor is listed in Table 4.

 

Table 4.  Designation of distal metastatic tumor (M1)

--------------------------------------------------------

Metastatic carcinoma in distant lymph nodes

        Hepatoduodenal

        Mesenteric

        Para-aortic

        Portal

        Retropancreatic

        Retroperitoneal

Metastatic carcinoma in distant organs

        Liver

        Lungs

        CNS

        Other less common organ sites

Metastatic carcinoma in peritoneal surfaces

Metastatic carcinoma in peritoneal cytology

----------------------------------------------------

 

 

DESIGNATION OF ANATOMIC STAGE

 

    The final grouping (staging) of gastric cancer is dependent on the appropriate designations of T, N, and M.  The anatomic stage, based on the current AJCC Cancer Staging Manual, is listed in Table 5. Of note, if there is uncertainty concerning the appropriate T, N, or M designation, the lower (less advanced) category should be assigned, in accordance with the general rules of staging.

 

Table 5   Anatomic Stage of Gastric Cancer*

 

_______________________________________________________________________

Stage 0                                     Tis                               N0                               M0

Stage IA                                   T1                                N0                               M0

Stage IB                                   T2                                N0                               M0

                                                T1                                N1                               M0

Stage IIA                                 T3                                N0                               M0

                                                T2                                N1                               M0

                                                T1                                N2                               M0

Stage IIB                                  T4a                               N0                               M0

                                                T3                                N1                               M0

                                                T2                                N2                               M0

                                                T1                                N3                               M0

Stage IIIA                                T4a                               N1                               M0

                                                T3                                N2                               M0

                                                T2                                N3                               M0

Stage IIIB                                T4b                               N0                               M0

                                                T4b                               N1                               M0

                                                T4a                               N2                               M0

                                                T3                                N3                               M0

Stage IIIC                                T4b                               N2                               M0

                                                T4b                               N3                M0                  

                                                T4a                               N3                               M0

Stage IV                         

                   Any   T           AnyN                          M1

________________________________________________________________________

 

* from the AJCC Cancer Staging Manual, 7th Edition.

 

标签:
本帖最后由 于 2010-05-04 12:37:00 编辑
0
添加参考诊断
×参考诊断
  

xuelang312 离线

帖子:9
粉蓝豆:24
经验:12
注册时间:2010-02-27
加关注  |  发消息
41 楼    发表于2010-09-27 20:19:00举报|引用
返回顶部 | 快捷回复

看来是需要刷新一下自己的记忆库了!谢谢谈老师!

0
回复

qingshui 离线

帖子:32
粉蓝豆:6
经验:394
注册时间:2010-09-13
加关注  |  发消息
42 楼    发表于2010-10-09 20:29:00举报|引用
返回顶部 | 快捷回复
 谢谢
0
回复

bjzhufeng 离线

帖子:421
粉蓝豆:19
经验:523
注册时间:2006-10-05
加关注  |  发消息
43 楼    发表于2010-10-10 12:24:00举报|引用
返回顶部 | 快捷回复
 谢谢!
0
回复
signature
快快悦悦工作

yyp8214136 离线

帖子:134
粉蓝豆:244
经验:355
注册时间:2007-05-23
加关注  |  发消息
44 楼    发表于2010-10-13 21:43:00举报|引用
返回顶部 | 快捷回复
学习
0
回复

坪子 离线

帖子:79
粉蓝豆:59
经验:117
注册时间:2006-10-21
加关注  |  发消息
45 楼    发表于2010-10-25 23:00:00举报|引用
返回顶部 | 快捷回复
 谢谢,学习了。
0
回复

骄阳如歌 离线

帖子:1138
粉蓝豆:12
经验:1531
注册时间:2009-12-13
加关注  |  发消息
46 楼    发表于2010-10-30 19:32:00举报|引用
返回顶部 | 快捷回复
 学习!谢谢!
0
回复
signature
做好生活中的每一件事,永远欣赏积极向上的精神!

fuxiaoxia 离线

帖子:8
粉蓝豆:1
经验:8
注册时间:2010-11-09
加关注  |  发消息
47 楼    发表于2010-11-25 19:40:00举报|引用
返回顶部 | 快捷回复
谢谢谈版主!好文章
0
回复

月舞 离线

帖子:20
粉蓝豆:2
经验:41
注册时间:2010-06-29
加关注  |  发消息
48 楼    发表于2010-11-30 15:29:00举报|引用
返回顶部 | 快捷回复
 学习,谢谢谈老师、谢谢njwbhuang 老师!!
0
回复

九天揽月 离线

帖子:423
粉蓝豆:35
经验:666
注册时间:2008-01-11
加关注  |  发消息
49 楼    发表于2010-12-09 17:01:00举报|引用
返回顶部 | 快捷回复
 谢谢谈东风老师!谢谢njwbhuang老师!谢谢SOS老师!
0
回复

yanjinputao 在线

帖子:49
粉蓝豆:408
经验:51
注册时间:2010-11-09
加关注  |  发消息
50 楼    发表于2010-12-18 18:43:00举报|引用
返回顶部 | 快捷回复
 谢谢老师!学习了!
0
回复
signature
赵文娣

jeaven 离线

帖子:438
粉蓝豆:198
经验:1088
注册时间:2009-07-04
加关注  |  发消息
51 楼    发表于2010-12-19 12:44:00举报|引用
返回顶部 | 快捷回复
 谢谢老师各位!学习了!
0
回复
signature
先做该做的事,再做想做的事

小点点 离线

帖子:198
粉蓝豆:1
经验:241
注册时间:2009-11-16
加关注  |  发消息
52 楼    发表于2010-12-25 10:10:00举报|引用
返回顶部 | 快捷回复
 谢谢老师,学习了!
0
回复

yhxuefeng 离线

帖子:2
粉蓝豆:1
经验:2
注册时间:2010-12-26
加关注  |  发消息
53 楼    发表于2010-12-26 08:21:00举报|引用
返回顶部 | 快捷回复
 有中文版吗
0
回复

大雪素 离线

帖子:1542
粉蓝豆:241
经验:8510
注册时间:2010-01-25
加关注  |  发消息
54 楼    发表于2011-01-05 11:19:00举报|引用
返回顶部 | 快捷回复
 谢谢
0
回复
signature
挺挺花卉中,竹有节而啬花,梅有花而啬叶,松有叶而啬香,唯兰独并有之

liziqiang88 离线

帖子:957
粉蓝豆:262
经验:3935
注册时间:2007-03-15
加关注  |  发消息
55 楼    发表于2011-01-25 17:25:00举报|引用
返回顶部 | 快捷回复
 谢谢谈老师各位老师的翻译
0
回复
signature
李自强

亭林人 离线

帖子:31
粉蓝豆:1
经验:49
注册时间:2009-12-22
加关注  |  发消息
56 楼    发表于2011-01-30 22:29:00举报|引用
返回顶部 | 快捷回复
 谢谢,实用啊
0
回复

Liu_Aijun 离线

帖子:1292
粉蓝豆:119
经验:1678
注册时间:2008-04-14
加关注  |  发消息
57 楼    发表于2011-02-15 22:52:00举报|引用
返回顶部 | 快捷回复
以下是引用九天揽月在2010-12-9 17:01:00的发言:

 谢谢谈东风老师!谢谢njwbhuang老师!谢谢SOS老师!

0
回复
signature
If you have great talents, industry will improve them; if you have but moderate abilities, industry will supply their deficiency. 如果你很有天赋,勤勉会使其更加完美;如果你能力一般,勤勉会补足其缺陷。

伊恋佳人 离线

帖子:1258
粉蓝豆:505
经验:1714
注册时间:2010-03-13
加关注  |  发消息
58 楼    发表于2011-02-15 23:53:00举报|引用
返回顶部 | 快捷回复
 谢谢老师!学习了!   
0
回复

dong 离线

帖子:48
粉蓝豆:1
经验:158
注册时间:2010-05-15
加关注  |  发消息
59 楼    发表于2011-02-21 22:31:00举报|引用
返回顶部 | 快捷回复
 看了谈老师提供的资料对日常工作很有帮助,我想请教一个问题,胃癌的T3和T4在临床工作中应如何理解,具体病理报告应如何书写。请老师结合解剖学给以详细讲解,万分感谢。
0
回复
signature
王占东

goshawk 离线

帖子:4
粉蓝豆:6
经验:41
注册时间:2010-01-21
加关注  |  发消息
60 楼    发表于2011-03-19 13:14:00举报|引用
返回顶部 | 快捷回复

 好文章

0
回复
回复:74 阅读:10101
共4页/73条首页上一页1234下一页尾页
【免责声明】讨论内容仅作学术交流之用,不作为诊疗依据,由此而引起的法律问题作者及本站不承担任何责任。
快速回复
进入高级回复
您最多可输入10000个汉字,按 "Ctrl" + "Enter" 直接发送
搜索回复/乘电梯 ×
按内容
按会员
乘电梯
合作伙伴
友情链接